Kestrel Therapeutics
Watertown, United States · $13.0M raised
- Headquarters
- Watertown, Massachusetts
- Business Model
- B2B
- Website
- kestreltherapeutics.com
- Total Funding
- $13.0M
- Last Round
- $8.0M Convertible NoteFeb 2025
- Rounds
- 2
About
Clinical-stage biotech pioneering small-molecule targeted therapies for intractable cancers.
Summary
Kestrel Therapeutics is a Biotech company based in Watertown, United States. It has raised $13.0M in total across 2 rounds, most recently a $8.0M Convertible Note round in Feb 2025. Investors include Pfizer Ventures, Cormorant Asset Management and Section 32.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...